Literature DB >> 23930488

Clinical characteristics of patients with hematological malignancies at gondar university hospital, North West Ethiopia.

Abilo Tadesse Weldetsadik1.   

Abstract

BACKGROUND: Hematological malignancies are primary cancers of the blood and blood-forming organs (bone marrow and lymphoid tissues), which includes leukemia, lymphoma and plasma cell dyscrasia. The overall incidence of hematological malignancies appears to be rising in United States of America and Europe, and estimated to be rising in Africa. This study was conducted as there is scarcity of information regarding clinical characteristics of hematological malignancies in Ethiopia.
OBJECTIVE: The study aims to determine the distribution and spectrum of various hematological malignancies encountered in the locality.
METHOD: This is a retrospective descriptive study done in Gondar University Hospital, North West Ethiopia from January 2008 to December 2011 in those admitted with the diagnosis of hematological malignancies.
RESULTS: Sixty-seven patients were admitted with the diagnosis of hematological malignancies during the study period The mean and median ages of patients with hematological malignancies were 42 yrs and 45 yrs respectively. Non-Hodgkin's lymphoma (NHL) comprised 22/67 (32.8%) of all hematological malignancies, followed by 17/67 (25.4%) chronic myeloid leukemia (CML) and 13/67 (19.4%) chronic lymphocytic leukemia (CLL). Majority of patients with NHL presented with advanced disease (77%), high-grade type (73%) with B-symptoms (68%), reflecting aggressive nature of the disease. Patients with acute leukemia, especially acute lymphoblastic leukemia (ALL), presented with features of cytopenia (fatigue, fever and bleeding tendency), while chronic leukemia (CML and CLL) cases had fatigue, weight loss and organomegally on admission. Among patients with CML, 12/17 (71%) were in chronic phase, 4/17 (23%) in accelerated phase and 1/17 (6%) in blast phase on admission. Majority of CLL patients had advanced disease on admission with 9/13 (69%) Binet C and 10/13 (76%) (Rai stage III and IV).
CONCLUSION: The distribution and spectrum of various hematological malignancies in this study is grossly similar to the pattern reported in other African countries.

Entities:  

Mesh:

Year:  2013        PMID: 23930488

Source DB:  PubMed          Journal:  Ethiop Med J        ISSN: 0014-1755


  3 in total

1.  Early molecular response in East African Philadelphia chromosome-positive chronic myeloid leukaemia patients treated with Imatinib and barriers to access treatment.

Authors:  Oliver Henke; Priscus John Mapendo; Elifuraha Wilson Mkwizu; Philipp le Coutre
Journal:  Ecancermedicalscience       Date:  2020-08-18

2.  Patterns of bone marrow aspiration confirmed hematological malignancies in Eritrean National Health Laboratory.

Authors:  Anim Ata Alamin; Natnael Belai; Amon Solomon Ghebrenegus; Amin Ata Alamin; Ghirmay Embaye; Amanuel Kidane Andegiorgish
Journal:  BMC Hematol       Date:  2019-05-02

3.  Presentation and survival in patients with hematologic malignancies in Jos, Nigeria: A retrospective cohort analysis.

Authors:  Ochaka J Egesie; Patricia A Agaba; Olugbenga A Silas; Chad Achenbach; Ayuba Zoakah; Oche O Agbaji; Jeremiah A Madaki; Edith N Okeke; Lifang Hou; Atiene S Sagay; Robert Murphy
Journal:  J Med Trop       Date:  2018-05-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.